Primary Record
voglibose
- In stock
- 9,013 g
- Purity
- 98.4 %
- CAS
- 83480-29-9
Compound Identifiers & Properties
- CAS
- 83480-29-9
- PubChem CID
- 444020
- SMILES
- C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO
- Canonical SMILES
- OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O
Names & Synonyms
- voglibose
- Basen
- Glustat
- Voglibosa
- 83480-29-9
- Voglibosum
- Vocarb
- Basen OD
- voglistat
- Bastamion
- Bayslowth
- Beglilat
- Beigrace
- Belderil
- Voglidase
- Voglise
- Vogseal
- Benjix
- Jumeal
- Berom
- Voglibose/
- voglibose OD
- Voglibose [INN]
- Beglilat OD
- Basen (TN)
- Volix (Ranbaxy labs)
- AO-128
- Voglibose [USAN:INN]
- Voglibosum [INN-Latin]
- Voglibosa [INN-Spanish]
- Voglibose Impurity 34
- VOGLIBOSE [JAN]
- VOGLIBOSE [MI]
- AC1L9FKA
- VOGLIBOSE [USAN]
- RefChem:902044
- GlyTouCan:G23864GM
- DTXSID2021442
- D04ZTY
- VOGLIBOSE [MART.]
- UNII-S77P977AG8
- SCHEMBL5882
- VOGLIBOSE [WHO-DD]
- CCRIS 4540
- CHEMBL476960
- DTXCID901442
- S77P977AG8
- C10H21NO7
- MLS003882582
- Voglibose - Bio-X trade mark
- AO 128
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N
- MFCD00865496
- N-(1,3-Dihydroxy-2-propyl)valiolamine
- orb1300524
- Basen (Takeda Chemical Industries)
- Voglibose (JP15/USAN/INN)
- Voglibose (JP18/USAN/INN)
- CHEBI:32300
- A10BF03
- AOB5593
- A-71100
- AO128
- BCPP000020
- DTXSID501031239
- GLXC-06681
- HMS3414A17
- HMS3678A17
- Voglibose, >=97.0% (TLC)
- VOGLIBOSE (REFERENCE GRADE)
- G23864GM
- HY-B0025
- KS-00000H9H
- MSK10642
- ZINC3788703
- Tox21_112220
- ABP000769
- BDBM50263044
- C10-H21-N-O7
- CID444020
- CV-051
- s4101
- AKOS015950839
- Tox21_112220_1
- (1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol
- CCG-267119
- CID:444020
- CS-2865
- CS-O-02553
- DB04878
- MV06910
- N-(1,3-Dihydroxyprop-2-yl)valiolamine
- NCGC00164595-01
- NCGC00164595-02
- BV164530
- SC-25677
- SMR002530327
- SY108971
- N,N-Bis[3-(methylamino)propyl]methylamine
- SID:134223911
- AB1004883
- CAS-83480-29-9
- J556.821H
- TL8005479
- A 71100
- B1870
- NS00069197
- A25630
- D01665
- AB01566929_01
- (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- 480V299
- C102817
- F818267
- SR-01000883931
- (1S,2S,3R,4S,5S)-5-[(1,3-dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- Q7939403
- SR-01000883931-1
- 3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol
- BRD-K66850609-001-01-7
- BRD-K66850609-001-05-8
- BRD-K66850609-001-07-4
- (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol
- 3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]A
- 3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epi-inositol
- (1S,2S,3R,4S,5S)-5-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- 112653-29-9
- 3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPINOSITOL
- 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol
- 3,4-Dideoxy-4-(2-hydroxy-1-(hydroxymethyl)ethylamino)-2-C-(hydroxymethyl)-D-epi-inositol
- 3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol
- (1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- (1S,2S,3R,4S,5S)-5-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- 3,4-Dideoxy-[2-hydroxy-1-(hydroxyethyl)ethyl] amino-1-C-(hydroxymethyl)-1,2,3,4-cyclohexaneterol
- 3,4-Dideoxy-[2-hydroxy-1-(hydroxyethyl)ethyl] amino-1-C-(hydroxynethyl)-1,2,3,4-cyclohexaneterol
- 3,4-Dideoxy-4-[[2-hy droxy-1-(hydr oxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol
- 3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epi-inositol; (1S,2S,3R,4S,5S)-5-((1,3-Dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol; (1S,2S,3R,4S,5S)-5-[(1,3-Dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol; A 71100; AO 128; Basen; Glustat; N-(1,3-Dihydroxy-2-propyl)valiolamine; Voglibose; Voglistat
- 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine
- D-epi-Inositol, 3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-
- VOG